Drawing for Serial No. 79329102

USPTO serial 79329102

Serial No. 79329102

Reviewed by CopyMark Law Group

Reg. 6848961Status 700Registered
Filing date
Status date
Registration date
Sep 20, 2022
Examiner
LAPTER, ALAIN J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79329102?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 7, 2023FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 11, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jan 11, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
Dec 20, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 20, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 20, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 19, 2022GPNXNOTIFICATION PROCESSED BY IB—
Jul 5, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 5, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 29, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 29, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 15, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 30, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 30, 2022XAECEXAMINER'S AMENDMENT ENTERED—
May 30, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 30, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
May 30, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
May 23, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 23, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 23, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 1, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 1, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 1, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 1, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 1, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 1, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 8, 2022RFNTREFUSAL PROCESSED BY IB—
Feb 14, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 14, 2022RFRRREFUSAL PROCESSED BY MPU—
Jan 25, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 24, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 21, 2022DOCKASSIGNED TO EXAMINER—
Jan 8, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 4, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 3, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 23, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance